Idiopathic Hypersomnia: Assessment, Treatments, Supplement Evidence and Safety
A clinical guide to persistent unexplained sleepiness, testing, adult treatment guidance, pregnancy and oxybate safety, with financial disclosures.
Evidence-graded research on sleep and insomnia — melatonin, magnesium and other sleep supplements assessed by the real strength of the primary evidence.
A clinical guide to persistent unexplained sleepiness, testing, adult treatment guidance, pregnancy and oxybate safety, with financial disclosures.
A cause-focused guide to adult central apnea, current conditional device and medicine recommendations, heart-failure safety, and source funding.
A source-screened guide to chronic and short-term insomnia, CBT-I, current combination-treatment guidance, medicine safety and funding.
A critical guide to restless legs syndrome, iron assessment, augmentation, magnesium and B6 evidence, medication safety and source funding.
What obstructive sleep apnea is, how diagnosis and treatment work, supplement limits, driving safety and the funding behind the evidence.
Chamomile sleep and anxiety trials, selected postpartum findings, allergy and medicine precautions, with reported funding, product-supply and source-access limits.
Oral lavender and Silexan anxiety, sleep and depression studies, product-specific precautions, medicine-interaction limits and reported manufacturer support.
Valerian sleep and anxiety findings, preparation-specific medicine rules, liver and sedation precautions, study limitations and reported funding.
Glycine sleep trials, short-term safety findings, formulation differences, company funding, unresolved disclosures and limits of the studied bedtime dose.
Independent review of agomelatine (Valdoxan): small benefit over placebo, good tolerability, unpublished trials, liver-test rules and who funded the evidence.
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.